VC Deals CareSync, a Tampa, Fla.-based provider of software and services for chronic disease management, has raised $18 million in Series B funding. Merck Global Health Innovation Fund, Greycroft [...]
Venture funding of healthtech companies in 2015 to date is ahead of 2014 YoY: funding to date exceeds $3.3B Key Trends Steady increase in mid stage (Series B and C) deals. Early stage deals hold [...]
VC Deals Deciphera Pharmaceuticals, a Waltham, Mass.-based developer of kinase inhibitor treatments targeting tumors cells, has raised $75 million in Series B funding led by New Leaf Venture [...]
VC Deals Mechio Inc. (dba Motiv), a San Francisco-based micro-wearables startup, has raised more than $8.6 million in Series A funding, according to a regulatory filing. Kleiner Perkins Caufield [...]
VC Deals Selecta Biosciences Inc., a Watertown, Mass.-based developer of targeted antigen-specific immune therapies, has raised $38 million in Series E funding. Existing shareholder OrbiMed [...]
VC Deals CeQur SA, a Swiss developer of insulin infusion solutions for people with diabetes, has raised $100 million in Series C funding. Woodford Investment Management and Arthurian Life [...]
VC Deals Editas Medicine, a Cambridge, Mass.-based genome editing company, has raised $120 million in Series B funding. Boris Nikolic led the round, on behalf of a U.S. investment company formed [...]
VC Deals LifeBond, an Israel-based developer of surgical sealants, has raised $27 million in Series D funding. Backers include Adams Street Partners, Sino Biopharmaceutical and return backers [...]
How to Get Funding: 3 Ways Successful Entrepreneurs Close Deals Fasterhttp://www.huffingtonpost.com/stephen-zarrilli/startup-funding_b_3046933.html
http://www.bloomberg.com/news/2013-03-25/sanofi-to-seek-more-venture-capital-deals-like-warp-drive.html